Vascular cell signaling by membrane estrogen receptors

Steroids

Volumn 73, Issue 9-10, 2008, Pages 864-869

  Kim, Kyung Hee ^a   Moriarty, Katie ^a   Bender, Jeffrey R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

c Src; Caveolin 1; eNOS; ER46; Estrogen

Indexed keywords

CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE;

ARTICLE; CAVEOLA; ENZYME ACTIVATION; HORMONE ACTION; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; AORTA; CERCOPITHECUS AETHIOPS; COS CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ESTROGENS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 44549084372     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2008.01.008     Document Type: Article

References (44)

1. Moncada S., and Higgs A. The l-arginine-nitric oxide pathway. N Engl J Med 329 (1993) 2002-2012
2. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100 (1997) 2153-2157
3. Stamper M.J., and Colditz G.A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20 (1991) 47-63
4. Grady D., Rubin S.M., Petitti D.B., Fox C.S., Black D., Ettinger B., et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117 (1992) 1016-1037
5. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
6. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al., Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280 (1998) 605-613
7. Mendelsohn M.E., and Karas R.H. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340 (1999) 1801-1811
8. Iafrati M.D., Karas R.H., Aronovitz M., Kim S., Sulliva Jr. T.R., Lubahn D.B., et al. Estrogen inhibits the vascular injury response in estrogen receptor-α-deficient mice. Nat Med 3 (1997) 545-548
9. Pare G., Krust A., Karas R.H., Dupont S., Aronovitz M., Chambon P., et al. Estrogen receptor-α mediates the protective effects of estrogen against vascular injury. Circ Res 90 (2002) 1087-1092
10. Karas R.H., Hodgin J.B., Kwoun K., Krege J.H., Aronovitz M., Mackey W., et al. Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice. Proc Natl Acad Sci USA 96 (1999) 15133-15136
11. Brouchet L., Krust A., Dupont S., Chambon P., Bayard F., and Arnal J.F. Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-α but not estrogen receptor-β. Circulation 103 (2001) 423-428
12. Figtree G.A., McDonald D., Watkins H., and Channon K.M. Truncated estrogen receptor α 46-kDa isoform in human endothelial cells. Circulation 107 (2003) 120-126
13. Li L., Haynes M.P., and Bender J.R. Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA 100 (2003) 4807-4812
14. Li L., Hisamoto K., Kim K.H., Haynes M.P., Bauer P.M., Sanjay A., et al. Variant estrogen receptor-c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activation. Proc Natl Acad Sci USA 104 (2007) 16468-16473
15. Pietras R.J., and Szego C.M. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 265 (1977) 69-72
16. Pietras R.J., and Szego C.M. Partial purification and characterization of estrogen receptors in subfractions of hepatocyte plasma membranes. Biochem J 191 (1980) 743-760
17. Pappas T.C., Gametchu B., and Watson C.S. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J 9 (1995) 404-410
18. Ropero A.B., Soria B., and Nadal A. A nonclassical estrogen membrane receptor triggers rapid differential actions in the endocrine pancreas. Mol Endocrinol 16 (2002) 497-505
19. Moriarty K., Kim K.H., and Bender J.R. Minireview: estrogen receptor-mediated rapid signaling. Endocrinology 147 (2006) 5557-5563
20. Acconcia F., Ascenzi P., Fabozzi G., Visca P., and Marino M. S-palmitoylation modulates human estrogen receptor-α functions. Biochem Biophys Res Commun 316 (2004) 878-883
21. Acconcia F., Ascenzi P., Bocedi A., Spisni E., Tomasi V., Trentalance A., et al. Palmitoylation-dependent estrogen receptor α membrane localization: regulation by 17β-estradiol. Mol Biol Cell 16 (2005) 231-237
22. Russell K.S., Haynes M.P., Sinha D., Clerisme E., and Bender J.R. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA 97 (2000) 5930-5935
23. Flouriot G., Brand H., Denger S., Metivier R., Kos M., Reid G., et al. Identification of a new isoform of the human estrogen receptor-alpha (hER-α) that is encoded by distinct transcripts and that is able to repress hER-α activation function 1. EMBO J 19 (2000) 4688-4700
24. Denger S., Reid G., Kos M., Flouriot G., Parsch D., Brand H., et al. ERα gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins. Mol Endocrinol 15 (2001) 2064-2077
25. Kim K.H., and Bender J.R. Rapid, estrogen receptor-mediated signaling: why is the endothelium so special?. Sci STKE 288 (2005) pe28
26. Castoria G., Migliaccio A., Bilancio A., Di Domenico M., de Falco A., Lombardi M., et al. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 20 (2001) 6050-6059
27. Razandi M., Alton G., Pedram A., Ghonshani S., Webb P., and Levin E.R. Identification of a structural determinant necessary for the localization and function of estrogen receptor α at the plasma membrane. Mol Cell Biol 23 (2003) 1633-1646
28. Song R.X., McPherson R.A., Adam L., Bao Y., Shupnik M., Kumar R., et al. Linkage of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation. Mol Endocrinol 16 (2002) 116-127
29. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., and Liao J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407 (2000) 538-541
30. Levin E.R. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 19 (2005) 1951-1959
31. Song R.X., Barnes C.J., Zhang Z., Bao Y., Kumar R., and Santen R.J. The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor α to the plasma membrane. Proc Natl Acad Sci USA 101 (2004) 2076-2081
32. Razandi M., Pedram A., Greene G.L., and Levin E.R. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol 13 (1999) 307-319
33. Razandi M., Pedram A., Merchenthaler I., Greene G.L., and Levin E.R. Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol 18 (2004) 2854-2865
34. Haynes M.P., Sinha D., Russell K.S., Collinge M., Fulton D., Morales-Ruiz M., et al. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 87 (2000) 677-682
35. Haynes M.P., Li L., Sinha D., Russell K.S., Hisamoto K., Baron R., et al. Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J Biol Chem 278 (2003) 2118-2123
36. Migliaccio A., Castoria G., Di Domenico M., de Falco A., Bilancio A., Lombardi M., et al. Steroid-induced androgen receptor-oestradiol receptor β-Src complex triggers prostate cancer cell proliferation. EMBO J 19 (2000) 5406-5417
37. Arnold S.F., Melamed M., Vorojeikina D.P., Notides A.C., and Sasson S. Estradiol-binding mechanism and binding capacity of the human estrogen receptor is regulated by tyrosine phosphorylation. Mol Endocrinol 11 (1997) 48-53
38. Wong C.W., McNally C., Nickbarg E., Komm B.S., and Cheskis B.J. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 99 (2002) 14783-14788
39. Kim H.P., Lee J.Y., Jeong J.K., Bae S.W., Lee H.K., and Jo I. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor α localized in caveolae. Biochem Biophys Res Commun 263 (1999) 257-262
40. Chambliss K.L., Yuhanna I.S., Anderson R.G., Mendelsohn M.E., and Shaul P.W. ERβ has nongenomic action in caveolae. Mol Endocrinol 16 (2002) 938-946
41. Kelly M.J., and Wagner E.J. Estrogen modulation of G-protein-coupled receptors. Trends Endocrinol Metab 10 (1999) 369-374
42. Hegy G.B., Shackleton C.H., Carlquist M., Bonn T., Engström O., Sjöholm P., et al. Carboxymethylation of the human estrogen receptor ligand-binding domain-estradiol complex: HPLC/ESMS peptide mapping shows that cysteine 447 does not react with iodoacetic acid. Steroids 61 (1996) 367-373
43. Pedram A., Razandi M., Sainson R.C., Kim J.K., Hughes C.C., and Levin E.R. A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 282 (2007) 22278-22288
44. Chambliss K.L., Yuhanna I.S., Mineo C., Liu P., German Z., Sherman T.S., et al. Estrogen receptor α and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res 87 (2000) E44-E52